Share-Based Compensation (Tables)

3 Months Ended

Apr. 30, 2016

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Stock-based compensation expense by type of grant

Stock-based compensation expense by type of grant for each period presented was as follows (in thousands):

	Three Months Ended
	April 30, 2016			May 2, 2015
Stock appreciation rights ("SARs")	$	—		$	30
Non-vested stock	1,736			1,606
Performance shares	1,073			1,073
Total compensation expense	2,809			2,709
Related tax benefit	(1,056		)	(1,019		)
Stock-based compensation expense, net of tax	$	1,753		$	1,690

Stock appreciation rights

The following table summarizes SARs activity for the three months endedApril 30, 2016:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)	Aggregate Intrinsic Value (in thousands)
Outstanding, vested and exercisable at January 30, 2016	224,400		$	17.16
Forfeited	(27,000	)	13.06
Outstanding, vested and exercisable at April 30, 2016	197,400		$	17.72	1.5	$	—

Non-vested stock

The following table summarizes non-vested stock activity for the three months endedApril 30, 2016:

Non-vested Stock	Number of Shares		Weighted Average Grant  Date Fair Value
Outstanding at January 30, 2016	894,526		$	20.20
Granted	1,086,645		7.14
Vested	(282,114	)	19.95
Forfeited	(22,547	)	19.33
Outstanding at April 30, 2016	1,676,510

Performance shares

The following table summarizes information about the performance shares that were outstanding at April 30, 2016:

Period Granted	Target Shares Outstanding at January 30, 2016	Target Shares Granted	Target Shares Vested	Target Shares Forfeited		Target Shares Outstanding at April 30, 2016	Weighted Average Grant Date Fair Value Per Share
2014	160,423	—	—	(2,292	)	158,131	$	33.84
2015	223,876	—	—	(3,809	)	220,067	28.33
2016	—	451,680	—	—		451,680	8.69
Total	384,299	451,680	—	(6,101	)	829,878